BioCryst Pharmaceuticals, Inc. (BCRX)
NASDAQ: BCRX · Real-Time Price · USD
9.83
-0.08 (-0.81%)
Jul 14, 2026, 11:58 AM EDT - Market open
BioCryst Pharmaceuticals Analyst Ratings
Ratings History
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| J.P. Morgan | J.P. Morgan | Hold Initiates $12 | Hold | Initiates | $12 | +22.08% | Jul 13, 2026 |
| RBC Capital | RBC Capital | Buy Maintains $13 → $14 | Buy | Maintains | $13 → $14 | +42.42% | Jul 7, 2026 |
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $32 | Buy | Maintains | $32 | +225.53% | Jun 30, 2026 |
| Wedbush | Wedbush | Buy Maintains $21 | Buy | Maintains | $21 | +113.63% | Jun 30, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $27 → $29 | Buy | Maintains | $27 → $29 | +195.02% | Jun 30, 2026 |
| Needham | Needham | Buy Maintains $16 | Buy | Maintains | $16 | +62.77% | Jun 29, 2026 |
| Citizens JMP | Citizens JMP | Buy Maintains $25 → $28 | Buy | Maintains | $25 → $28 | +184.84% | May 7, 2026 |
| TD Cowen | TD Cowen | Buy Maintains $30 | Buy | Maintains | $30 | +205.19% | May 6, 2026 |
Upgrade to Pro
Get stock forecasts from Wall Street's highest rated professionals
Get much more with Stock Analysis Pro
- Investment ideas from the top Wall Street analysts
- Unlimited access to all data and tools
- Advanced analyst filtering and sorting options
- Up to 3 years of analyst rating history
Analyst Star Rankings
Our analyst star rankings are based on these four factors
- Success Rate
- The percentage of ratings that are profitable.
- Average Return
- The average percentage return within one year of the rating.
- Rating Count
- The more ratings the analyst has provided, the higher the score.
- Recency
- Ratings provided within the past year contribute to a higher score.